Johan Harmenberg is Chief Medical Officer at Oncopeptides AB and medical advisor to Beactica since 2019. He has previously held roles at a number of life sciences companies including as CEO for Axelar AB and Akinion AB, Chief Medical Officer at Algeta AB, Vice President Development for Medivir AB and Global Medical Director for Pharmacia Upjohn. He is the author of over 100 publications for a range of scientific journals. Johan holds a Ph.D. and M.D. from the Karolinska Institute in Stockholm, Sweden. He is also Associate Professor (Docent) at the same institution.
Sign up for the Beactica newsletter to recieve our latest news and updates